JNJ-38877605

· Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JNJ-38877605, covering 2013-03-08 to 2013-03-08. Get the full timeline:

Most recent: Clinical Trial Update: A Safety and Dose-finding Study of JNJ-38877605 in Patients With Advanced or Refractory Solid Tumors. [Phase 1]